Gajanand Agarwal
Directeur/Membre du Conseil chez Unidrug Innovative Pharma Technologies Ltd.
Profil
Gajanand Agarwal is currently an Independent Director at Unidrug Innovative Pharma Technologies Ltd.
and an Associate at Indian Institute of Banking & Finance.
He has an undergraduate and graduate degree from Devi Ahilya University.
Postes actifs de Gajanand Agarwal
| Sociétés | Poste | Début |
|---|---|---|
Unidrug Innovative Pharma Technologies Ltd.
 Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Directeur/Membre du Conseil | 20/09/2018 |
| Indian Institute of Banking & Finance | Corporate Officer/Principal | - |
Formation de Gajanand Agarwal
| Devi Ahilya University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Unidrug Innovative Pharma Technologies Ltd.
Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Health Technology |
